Romel Montellano

Romel Montellano has extensive experience in regulatory operations and affairs. Romel most recently held the position of Senior Director of Regulatory Operations at Mirati Therapeutics, where they started in 2017. Prior to this, they worked as the Director of Regulatory Operations at the same company. Before joining Mirati Therapeutics, they served as the Associate Director of Clinical Document Management at Tocagen from 2016 to 2017. Romel also held regulatory operations positions at Neothetics and Halozyme Therapeutics, Inc., where they progressively advanced in roles such as Associate Director, Manager, and Senior Publication Specialist. Montellano's earlier career includes roles at Neurocrine Biosciences, Elan Pharmaceuticals, and Quintiles, where they gained experience in regulatory affairs and operations. Overall, Montellano has over 20 years of experience in the field and has held various leadership positions throughout their career.

Romel Montellano holds a Master of Business Administration (M.B.A.) degree from San Diego State University. Additionally, they completed a Professional Certificate in Regulatory Affairs for the Biomedical Industry from UC San Diego Extended Studies. Romel also earned a Bachelor's degree in Psychology from UC San Diego.